Vladimír Frýba

570 total citations
12 papers, 177 citations indexed

About

Vladimír Frýba is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Vladimír Frýba has authored 12 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Vladimír Frýba's work include Pancreatic and Hepatic Oncology Research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). Vladimír Frýba is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). Vladimír Frýba collaborates with scholars based in Czechia and Uzbekistan. Vladimír Frýba's co-authors include Tomáš Zima, Michal Vočka, Luboš Petruželka, J Petrtýl, Marta Kalousová, Tomáš Hanuš, Daniël Langer, Jan Ulrych, Z Krška and J Kvasnička and has published in prestigious journals such as Scientific Reports, Pathology & Oncology Research and BMC Surgery.

In The Last Decade

Vladimír Frýba

10 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vladimír Frýba Czechia 7 51 47 40 34 28 12 177
Ayako Nagasawa Japan 6 57 1.1× 63 1.3× 21 0.5× 12 0.4× 29 1.0× 17 242
Taketoshi Nara Japan 10 83 1.6× 43 0.9× 78 1.9× 26 0.8× 64 2.3× 42 277
Jiakang Shen China 8 57 1.1× 51 1.1× 23 0.6× 13 0.4× 32 1.1× 30 161
Julien Rohmer France 6 31 0.6× 17 0.4× 7 0.2× 30 0.9× 20 0.7× 13 111
Ailith Ewing United Kingdom 6 41 0.8× 44 0.9× 30 0.8× 4 0.1× 12 0.4× 7 152
Shuai Hu China 10 63 1.2× 77 1.6× 81 2.0× 24 0.7× 46 1.6× 18 310
Kelly Ambler United States 2 59 1.2× 50 1.1× 27 0.7× 14 0.4× 29 1.0× 3 251
Julia Martínez-Sánchez Spain 9 69 1.4× 19 0.4× 31 0.8× 6 0.2× 10 0.4× 20 233
Koichi Takayama Japan 6 39 0.8× 15 0.3× 58 1.4× 35 1.0× 31 1.1× 18 166
Genki Usui Japan 9 100 2.0× 82 1.7× 80 2.0× 5 0.1× 51 1.8× 25 292

Countries citing papers authored by Vladimír Frýba

Since Specialization
Citations

This map shows the geographic impact of Vladimír Frýba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimír Frýba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimír Frýba more than expected).

Fields of papers citing papers by Vladimír Frýba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimír Frýba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimír Frýba. The network helps show where Vladimír Frýba may publish in the future.

Co-authorship network of co-authors of Vladimír Frýba

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimír Frýba. A scholar is included among the top collaborators of Vladimír Frýba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimír Frýba. Vladimír Frýba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vočka, Michal, Luboš Petruželka, Miroslav Ryska, et al.. (2023). Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma. Neoplasma. 70(3). 468–475.
2.
Hojný, J., Michaela Bártů, Kristýna Němejcová, et al.. (2020). Identification of novel HNF1B mRNA splicing variants and their qualitative and semi-quantitative profile in selected healthy and tumour tissues. Scientific Reports. 10(1). 6958–6958. 7 indexed citations
3.
Ulrych, Jan, Václava Adámková, Martin Komarc, et al.. (2020). Intra-abdominal candidiasis in surgical intensive care unit - epidemiology characteristics and trends.. PubMed. 69(2). 57–63. 4 indexed citations
4.
Bártů, Michaela, J. Hojný, Nikola Hájková, et al.. (2020). Expression, Epigenetic, and Genetic Changes of HNF1B in Colorectal Lesions: an Analysis of 145 Cases. Pathology & Oncology Research. 26(4). 2337–2350. 6 indexed citations
5.
Frýba, Vladimír, Luboš Petruželka, Vladimı́r Setnička, et al.. (2020). Novel spectroscopic biomarkers are applicable in non-invasive early detection and staging classification of colorectal cancer. Neoplasma. 67(6). 1349–1358. 5 indexed citations
6.
Vočka, Michal, Daniël Langer, Vladimír Frýba, et al.. (2019). Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer. The International Journal of Biological Markers. 34(3). 292–301. 33 indexed citations
7.
Frýba, Vladimír, et al.. (2019). Focal infl ammatory liver lesions. 73(6). 501–508.
8.
Vočka, Michal, Daniël Langer, Vladimír Frýba, et al.. (2019). Novel serum markers HSP60, CHI3L1, and IGFBP-2 in metastatic colorectal cancer. Oncology Letters. 18(6). 6284–6292. 30 indexed citations
9.
Vočka, Michal, Daniël Langer, Vladimír Frýba, et al.. (2018). Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer. Cancer Biomarkers. 21(4). 869–874. 37 indexed citations
10.
Ulrych, Jan, Tomáš Kvasnička, Vladimír Frýba, et al.. (2018). The impact of hereditary thrombophilia on the incidence of postoperative venous thromboembolism in colorectal cancer patients: a prospective cohort study. European surgery. Supplement/European surgery. 51(1). 5–12. 3 indexed citations
11.
Ulrych, Jan, Tomáš Kvasnička, Vladimír Frýba, et al.. (2016). 28 day post-operative persisted hypercoagulability after surgery for benign diseases: a prospective cohort study. BMC Surgery. 16(1). 16–16. 26 indexed citations
12.
Ulrych, Jan, Vladimír Frýba, Helena Skálová, et al.. (2015). Premalignant and Malignant Lesions of the Heterotopic Pancreas in the Esophagus: a Case Report and Review of the Literature. Journal of Gastrointestinal and Liver Diseases. 24(2). 235–239. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayako Nagasawa Breakdown of academic impact, for papers by Taketoshi Nara Breakdown of academic impact, for papers by Jiakang Shen Breakdown of academic impact, for papers by Julien Rohmer Breakdown of academic impact, for papers by Ailith Ewing Breakdown of academic impact, for papers by Shuai Hu Breakdown of academic impact, for papers by Kelly Ambler Breakdown of academic impact, for papers by Julia Martínez-Sánchez Breakdown of academic impact, for papers by Koichi Takayama Breakdown of academic impact, for papers by Genki Usui
Rankless by CCL
2026